Ausgabe 1/2014
Inhalt (23 Artikel)
The non-coding transcriptome as a dynamic regulator of cancer metastasis
Francesco Crea, Pier Luc Clermont, Abhijit Parolia, Yuzhuo Wang, Cheryl D. Helgason
Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition
Benoît Thibault, Magali Castells, Jean-Pierre Delord, Bettina Couderc
Dietary phytochemicals alter epigenetic events and signaling pathways for inhibition of metastasis cascade
B. N. Singh, Harikesh Bahadur Singh, A. Singh, Alim H. Naqvi, Braj Raj Singh
Netrin-1 as a potential target for metastatic cancer: focus on colorectal cancer
Suh Youn Ko, Gregory L. Blatch, Crispin R. Dass
Ribosomal proteins as novel players in tumorigenesis
A. de las Heras-Rubio, L. Perucho, R. Paciucci, J. Vilardell, M. E. LLeonart
Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine
Sarah Derks, Arjen H. G. Cleven, Veerle Melotte, Kim M. Smits, Johann C. Brandes, Nilofer Azad, Wim van Criekinge, Adriaan P. de Bruïne, James G. Herman, Manon van Engeland
The dual functions of YAP-1 to promote and inhibit cell growth in human malignancy
Hai Wang, Yu-Chen Du, Xiao-jun Zhou, Hong Liu, Shou-Ching Tang
Oxygen regulates molecular mechanisms of cancer progression and metastasis
Kartik Gupta, Esha Madan, Muzzammil Sayyid, Hugo Arias-Pulido, Eduardo Moreno, Periannan Kuppusamy, Rajan Gogna
Calories, carbohydrates, and cancer therapy with radiation: exploiting the five R’s through dietary manipulation
Rainer J. Klement, Colin E. Champ
Platelets and cancer: a casual or causal relationship: revisited
David G. Menter, Stephanie C. Tucker, Scott Kopetz, Anil K. Sood, John D. Crissman, Kenneth V. Honn
Concomitant resistance and early-breast cancer: should we change treatment strategies?
Carlos M. Galmarini, Olivier Tredan, Felipe C. Galmarini
Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumors
Alberto Ocaña, Orit Freedman, Eitan Amir, Bostjan Seruga, Atanasio Pandiella
Adoptive immunotherapy of metastatic breast cancer: present and future
Stefan Stefanovic, Florian Schuetz, Christof Sohn, Philipp Beckhove, Christoph Domschke
Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside
Matteo Santoni, Daniele Santini, Francesco Massari, Alessandro Conti, Roberto Iacovelli, Luciano Burattini, Giampaolo Tortora, Massimo Falconi, Rodolfo Montironi, Stefano Cascinu
Bone metastases in hepatocellular carcinoma: an emerging issue
Vito Longo, Oronzo Brunetti, Stella D’Oronzo, Carmela Ostuni, Pietro Gatti, Franco Silvestris
Gastroenteropancreatic neuroendocrine tumors: current perspectives and future challenges
Rocio Garcia-Carbonero
Molecular biology of neuroendocrine tumors: from pathways to biomarkers and targets
J. Capdevila, A. Meeker, R. García-Carbonero, K. Pietras, A. Astudillo, O. Casanovas, A. Scarpa
Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenges
J. P. Castaño, A. Sundin, H. R. Maecke, C. Villabona, R. Vazquez-Albertino, E. Navarro, K. Öberg
Pancreatic NETs: where do we stand now?
S. Faivre, D. Castellano, J. Strosberg, E. González, R. Salazar
Systemic therapeutic strategies for GEP-NETS: what can we expect in the future?
E. Raymond, R. García-Carbonero, B. Wiedenmann, E. Grande, M. Pavel